03:12 AM EST, 01/24/2025 (MT Newswires) -- Jeffrey W. Albers, Director, on January 21, 2025, sold 15,161 shares in Blueprint Medicines ( BPMC ) for $1,660,511. Following the Form 4 filing with the SEC, Albers has control over a total of 152,396 shares of the company, with 152,396 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1597264/000141588925001989/xslF345X05/form4-01242025_120158.xml